We found that SSc patients with Gal-9 levels >P75, had lower FVC (% Pred) (p<0.001), TLC (% Pred) (p<0.001), and DLCO SB (% Pred) (p=0.001) (Figures 4A–C). This evidence concerns the gene LGALS9 and systemic sclerosis.